CGTX Cognition Therapeutics, Inc. - Common Stock
$0,99
Harga · Agu 19, 2026
Fundamental per Agu 7, 2026
Rentang 52M
$1–$4
13% of range
Peringkat Analis
BUY
9 analysts
Target Harga
$3
+238% upside
P/E (TTM)
-3.1
ROE
-113.7%
Margin Laba Bersih
—
CGTX Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$0.99
Kapitalisasi Pasar
$88M
P/E (TTM)
-3.1
EPS (TTM)
$-0.32
Pendapatan (TTM)
—
Imbal Hasil Dividen
—
ROE
-113.7%
D/E Utang/Ekuitas
—
Rentang 52M
$1 – $4
CGTX Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Configure
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan & Laba Bersih
—
EPS
$-0.32
2020-12-31
→
2025-12-31
Arus Kas Bebas
—
2021-12-31
→
2024-12-31
Margin
—
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Metrik
Tren 5 Tahun
CGTX
Median Rekan
P/E (TTM)
-3.1
44.2
P/S (TTM)
-3128.2
15.5
P/B
2.6
3.3
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Metrik
Tren 5 Tahun
CGTX
Median Rekan
ROA
-59.8%
-62.1%
ROE
-113.7%
-79.9%
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Metrik
Tren 5 Tahun
CGTX
Median Rekan
Current Ratio (Rasio Lancar)
3.4
3.4
Quick Ratio (Rasio Cepat)
2.6
—
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Metrik
Tren 5 Tahun
CGTX
Median Rekan
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Metrik
Tren 5 Tahun
CGTX
Median Rekan
CGTX Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
BELI
9 analis
- Beli Kuat 2 22,2%
- Beli 6 66,7%
- Tahan 1 11,1%
- Jual 0 0,0%
- Jual Kuat 0 0,0%
Target Harga 12 Bulan
3 analis · 2026-08-15
Median
$3.00
Rata-rata
$3.33
← Di bawah semua target
$0.99
Rendah
$3.00
Tinggi
$4.00
Target median
$3.00
+204,5%
Target rata-rata
$3.33
+238,3%
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
0.01%
| Periode | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|
| 30 Juni 2026 | $-0.04 | $-0.06 | 0.02% |
| 31 Maret 2026 | $-0.05 | $-0.07 | 0.02% |
| 31 Des. 2025 | $-0.05 | $-0.09 | 0.04% |
| 30 Sep. 2025 | $-0.06 | $-0.10 | 0.04% |
| 30 Juni 2025 | $-0.11 | $-0.11 | -0.00% |
| 31 Maret 2025 | $-0.14 | $-0.11 | -0.03% |
| 31 Des. 2024 | $-0.17 | $-0.14 | -0.03% |
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| CGTX | $120M | -4.2 | — | — | -113.7% | — |
| CPIX | $60M | -20.9 | 17.6% | -6.4% | -11.9% | — |
| PLYX | — | — | — | — | -193.7% | — |
| RFL | — | -1.6 | 44.0% | -3328.2% | -34.6% | — |
| VRCA | $143M | -4.9 | 370.2% | -50.3% | -492.8% | — |
| TELO | $46M | -4.0 | — | — | -325.7% | — |
| LONA | $71M | -0.3 | — | — | -353.4% | — |
| CING | — | — | — | — | — | — |
| ELOX | — | — | — | — | 30.1% | — |
| PLRX | $75M | -0.5 | -83.7% | — | -74.4% | — |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi 12
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $37M | $42M | $37M | $30M | $19M | $13M | |
| SG&A Expense | $11M | $12M | $14M | $13M | $10M | $5M | |
| Operating Expenses | $48M | $54M | $51M | $44M | $29M | $17M | |
| Operating Income | $-48M | $-54M | $-51M | $-44M | $-29M | $-17M | |
| Other Non-op | $24M | $20M | $25M | $22M | $17M | $10M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | · | |
| Net Income | $-23M | $-34M | $-26M | $-21M | $-12M | $-8M | |
| EPS (Basic) | $-0.32 | $-0.86 | $-0.86 | $-0.91 | $-3.13 | $-23.76 | |
| EPS (Diluted) | $-0.32 | $-0.86 | $-0.86 | $-0.91 | $-3.13 | $-23.76 | |
| Shares (Basic) | 72,766,983 | 39,730,148 | 30,029,087 | 23,640,199 | 5,190,883 | 508,112 | |
| Shares (Diluted) | 72,766,983 | 39,730,148 | 30,029,087 | 23,640,199 | 5,190,883 | 508,112 | |
| EBITDA | $-48M | $-54M | $-51M | $-43M | $-29M | · |
Neraca 22
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $37M | $25M | $30M | $42M | $55M | $5M | |
| Prepaid Expense | $1M | $2M | $3M | $2M | $2M | $544.0K | |
| Other Current Assets | · | · | · | · | $11.0K | $23.0K | |
| Current Assets | $48M | $30M | $34M | $48M | $59M | $7M | |
| PP&E (Net) | $93.0K | $181.0K | $284.0K | $233.0K | $145.0K | $211.0K | |
| PP&E (Gross) | $280.0K | $1M | $1M | $1M | $1M | $988.0K | |
| Accum. Depreciation | $187.0K | $1M | $1M | $953.0K | $870.0K | $777.0K | |
| Total Assets | $48M | $30M | $35M | $50M | $59M | $7M | |
| Accounts Payable | $1M | $2M | $4M | $3M | $4M | $2M | |
| Accrued Liabilities | $12M | $8M | $4M | $2M | $2M | $994.0K | |
| Current Liabilities | $14M | $11M | $10M | $8M | $8M | $3M | |
| Capital Leases | $195.0K | $342.0K | $520.0K | $695.0K | · | · | |
| Deferred Tax | $67.0K | $110.0K | $147.0K | $178.0K | $13.0K | $22.0K | |
| Other Non-current Liabilities | · | · | $0 | $2M | $0 | · | |
| Total Liabilities | $14M | $11M | $11M | $10M | $8M | $20M | |
| Common Stock | $90.0K | $60.0K | $32.0K | $29.0K | $22.0K | $1.0K | |
| Paid-in Capital | $233M | $194M | $166M | $156M | $145M | $222.0K | |
| Retained Earnings | $-199M | $-175M | $-141M | $-115M | $-94M | $-68M | |
| AOCI | · | · | $-195.0K | $-199.0K | $-198.0K | $-187.0K | |
| Stockholders' Equity | $34M | $19M | $24M | $40M | $51M | $-68M | |
| Liabilities + Equity | $48M | $30M | $35M | $50M | $59M | $7M | |
| Shares Outstanding | 88,904,161 | 59,854,877 | 32,165,478 | 28,991,548 | 22,230,032 | 538,793 |
Arus Kas 10
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $36.0K | $107.0K | $96.0K | $83.0K | $93.0K | $98.0K | |
| Stock-based Comp | $2M | $4M | $4M | $4M | $5M | $475.0K | |
| Deferred Tax | · | $0 | $0 | $0 | · | · | |
| Other Non-cash | $-3M | $2M | $5M | $-791.0K | $3M | · | |
| Operating Cash Flow | $-25M | $-28M | $-16M | $-19M | $-4M | $-3M | |
| CapEx | · | $4.0K | $147.0K | $171.0K | $27.0K | $10.0K | |
| Investing Cash Flow | $9.0K | $-4.0K | $-147.0K | $-171.0K | $-27.0K | $-10.0K | |
| Financing Cash Flow | $37M | $24M | $5M | $6M | $53M | $6M | |
| Net Change in Cash | $12M | $-5M | $-12M | $-13M | $50M | $2M | |
| Free Cash Flow | · | $-28M | $-16M | $-19M | $-4M | · |
Profitabilitas 5
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | 187866.7% | 155539.3% | 3202.5% | · | |
| Net Margin | · | · | 95511.1% | 76417.9% | 1312.0% | · | |
| EBITDA Margin | · | · | 187511.1% | 155242.9% | 3192.1% | · | |
| ROA | -59.8% | -103.9% | -60.3% | -39.1% | -35.4% | · | |
| ROE | -113.7% | -204.5% | -96.6% | -53.8% | 66.1% | · |
Likuiditas & Solvabilitas 2
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | 2.7 | 3.4 | 6.1 | 7.5 | · | |
| Quick Ratio | 2.6 | 2.2 | 2.9 | 5.3 | 7.0 | · |
Efisiensi 1
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | -0.0 | -0.0 | -0.0 | · |
Valuasi (TTM) 10
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $-28.0K | $-28.0K | $-27.0K | $-28.0K | $-893.0K | · | |
| Net Income TTM | $-23M | $-34M | $-26M | $-21M | $-12M | · | |
| Market Cap | $120M | $42M | $60M | $61M | $140M | · | |
| P/E | -4.2 | -0.8 | -2.2 | -2.3 | -2.0 | · | |
| P/S | -4286.5 | -1498.5 | -2203.9 | -2174.4 | -157.3 | · | |
| P/B | 3.5 | 2.2 | 2.4 | 1.5 | 2.7 | · | |
| P / Tangible Book | 3.5 | 2.2 | 2.4 | 1.5 | 2.7 | · | |
| P / Cash Flow | -4.9 | -1.5 | -3.7 | -3.3 | -38.7 | · | |
| P / FCF | · | -1.5 | -3.7 | -3.3 | -38.4 | · | |
| Earnings Yield | -23.7% | -122.7% | -46.5% | -43.3% | -49.5% | · |
Laporan Laba Rugi 12
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $5M | $6M | $11M | $4M | $11M | $11M | $8M | $11M | $12M | $11M | $12M | $12M | $8M | $5M | $6M | $8M | |
| SG&A Expense | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $3M | $4M | $4M | $3M | $3M | $4M | $3M | $4M | |
| Operating Expenses | $8M | $9M | $14M | $6M | $14M | $14M | $11M | $14M | $15M | $14M | $15M | $15M | $12M | $9M | $9M | $13M | |
| Operating Income | $-8M | $-9M | $-14M | $-6M | $-14M | $-14M | $-11M | $-14M | $-15M | $-14M | $-15M | $-15M | $-12M | $-9M | $-9M | $-13M | |
| Other Non-op | $4M | $4M | $10M | $1M | $7M | $5M | $3M | $5M | $8M | $5M | $7M | $8M | $7M | $3M | $4M | $6M | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | · | · | $-5M | $-6M | · | · | |
| Net Income | $-4M | $-5M | $-3M | $-5M | $-7M | $-8M | $-8M | $-10M | $-7M | $-9M | $-8M | $-7M | $-5M | $-6M | $-5M | $-7M | |
| EPS (Basic) | $-0.04 | $-0.05 | $-0.01 | $-0.06 | $-0.11 | $-0.14 | $-0.16 | $-0.25 | $-0.18 | $-0.27 | $-0.27 | $-0.22 | $-0.16 | $-0.21 | $-0.20 | $-0.29 | |
| EPS (Diluted) | $-0.04 | $-0.05 | $-0.01 | $-0.06 | $-0.11 | $-0.14 | $-0.16 | $-0.25 | $-0.18 | $-0.27 | $-0.27 | $-0.22 | $-0.16 | $-0.21 | $-0.20 | $-0.29 | |
| Shares (Basic) | 90,624,381 | 89,191,313 | -130,703,624 | 77,951,513 | 63,690,945 | 61,828,149 | -74,486,140 | 40,418,065 | 40,062,954 | 33,735,269 | -59,045,833 | 30,365,506 | 29,614,822 | 29,094,592 | -44,406,168 | 23,024,026 | |
| Shares (Diluted) | 90,624,381 | 89,191,313 | -130,703,624 | 77,951,513 | 63,690,945 | 61,828,149 | -74,486,140 | 40,418,065 | 40,062,954 | 33,735,269 | -59,045,833 | 30,365,506 | 29,614,822 | 29,094,592 | -44,406,168 | 23,024,026 | |
| EBITDA | $-8M | $-9M | · | $-6M | $-14M | $-14M | · | $-14M | $-15M | $-14M | · | $-15M | $-12M | $-9M | · | $-13M |
Neraca 21
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $34M | $31M | $37M | $39M | $11M | $16M | $25M | $22M | $29M | $35M | $30M | $33M | $37M | $39M | $42M | $47M | |
| Prepaid Expense | $586.0K | $932.0K | $1M | $1M | $1M | $2M | $2M | $1M | $2M | $2M | $3M | $1M | $2M | $2M | $2M | $2M | |
| Current Assets | $38M | $36M | $48M | $43M | $19M | $23M | $30M | $27M | $34M | $38M | $34M | $36M | $42M | $43M | $48M | $51M | |
| PP&E (Net) | $87.0K | $77.0K | $93.0K | $159.0K | $174.0K | $190.0K | $181.0K | $207.0K | $234.0K | $257.0K | $284.0K | $281.0K | $248.0K | $253.0K | $233.0K | $246.0K | |
| PP&E (Gross) | · | · | $280.0K | · | · | · | $1M | · | · | · | $1M | · | · | · | $1M | · | |
| Accum. Depreciation | · | · | $187.0K | · | · | · | $1M | · | · | · | $1M | · | · | · | $953.0K | · | |
| Total Assets | $39M | $36M | $48M | $43M | $20M | $24M | $30M | $28M | $34M | $39M | $35M | $39M | $44M | $46M | $50M | $54M | |
| Accounts Payable | $673.0K | $4M | $1M | $827.0K | $771.0K | $2M | $2M | $2M | $3M | $3M | $4M | $3M | $4M | $3M | $3M | $8M | |
| Accrued Liabilities | $4M | $2M | $12M | $4M | $9M | $8M | $8M | $10M | $6M | $5M | $4M | $4M | $2M | $2M | $2M | $2M | |
| Current Liabilities | $5M | $6M | $14M | $7M | $12M | $11M | $11M | $13M | $11M | $10M | $10M | $8M | $8M | $7M | $8M | $12M | |
| Capital Leases | $422.0K | $176.0K | $195.0K | $212.0K | $229.0K | $280.0K | $342.0K | $392.0K | $440.0K | $488.0K | $520.0K | $565.0K | $608.0K | $651.0K | $695.0K | $603.0K | |
| Deferred Tax | · | · | $67.0K | · | · | · | $110.0K | · | · | · | $147.0K | · | · | · | $178.0K | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | $0 | $0 | $0 | · | $1M | $1M | $2M | $2M | $2M | |
| Total Liabilities | $6M | $6M | $14M | $7M | $13M | $11M | $11M | $13M | $11M | $10M | $11M | $10M | $10M | $10M | $10M | $14M | |
| Common Stock | $95.0K | $90.0K | $90.0K | $88.0K | $65.0K | $62.0K | $60.0K | $41.0K | $40.0K | $40.0K | $32.0K | $30.0K | $30.0K | $29.0K | $29.0K | $24.0K | |
| Paid-in Capital | $240M | $233M | $233M | $232M | $197M | $196M | $194M | $182M | $180M | $179M | $166M | $162M | $161M | $158M | $156M | $150M | |
| Retained Earnings | $-207M | $-203M | $-199M | $-195M | $-190M | $-184M | $-175M | $-167M | $-157M | $-150M | $-141M | $-133M | $-126M | $-122M | $-115M | $-110M | |
| AOCI | · | · | · | · | · | · | · | · | · | · | $-195.0K | $-196.0K | $-196.0K | $-195.0K | $-199.0K | $-201.0K | |
| Stockholders' Equity | $33M | $30M | $34M | $37M | $7M | $12M | $19M | $14M | $23M | $29M | $24M | $29M | $34M | $36M | $40M | $39M | |
| Liabilities + Equity | $39M | $36M | $48M | $43M | $20M | $24M | $30M | $28M | $34M | $39M | $35M | $39M | $44M | $46M | $50M | $54M | |
| Shares Outstanding | 95,055,773 | 89,353,773 | 88,904,161 | 88,268,078 | 64,962,957 | 61,974,755 | 59,854,877 | 40,806,092 | 40,112,268 | 39,985,866 | 32,165,478 | 30,417,082 | 30,286,582 | 29,277,227 | 28,991,548 | 23,969,497 |
Arus Kas 11
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $14.0K | $15.0K | · | · | $27.0K | $27.0K | $26.0K | $27.0K | $27.0K | $25.0K | $23.0K | $21.0K | $23.0K | $22.0K | |
| Stock-based Comp | $319.0K | $330.0K | $358.0K | $522.0K | $621.0K | $586.0K | $534.0K | $896.0K | $1M | $1M | $1M | $1M | $1M | $1M | $902.0K | $777.0K | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $709.0K | · | · | · | $2M | · | · | |
| Operating Cash Flow | $-3M | $-6M | $-3M | $-6M | $-6M | $-10M | $-8M | $-7M | $-6M | $-7M | $-5M | $-4M | $-4M | $-3M | $-10M | $-4.0K | |
| CapEx | · | · | · | · | · | · | $1.0K | $0 | · | · | $30.0K | $58.0K | $18.0K | $41.0K | $10.0K | $23.0K | |
| Investing Cash Flow | · | · | · | · | · | · | $-1.0K | $0 | · | · | $-30.0K | $-58.0K | $-18.0K | $-41.0K | $-10.0K | $-23.0K | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | $2M | $197.0K | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $197.0K | · | · | |
| Financing Cash Flow | $7M | $-233.0K | $605.0K | $34M | $752.0K | $1M | $11M | $329.0K | $-138.0K | $12M | $2M | $-3.0K | $2M | $-10.0K | $5M | $869.0K | |
| Net Change in Cash | $4M | $-6M | $-3M | $28M | $-5M | $-9M | $3M | $-7M | $-6M | $5M | $-3M | $-4M | $-2M | $-3M | $-5M | $839.0K | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | $-3M | · | · |
Profitabilitas 6
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | · | 141020.0% | · | 737250.0% | 196950.0% | 89730.0% | · | 631250.0% | |
| Net Margin | · | · | · | · | · | · | · | · | · | 91510.0% | · | 337450.0% | 78766.7% | 61720.0% | · | 331250.0% | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | · | · | 78766.7% | 61720.0% | · | · | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | 140750.0% | · | 737250.0% | 196950.0% | 89520.0% | · | 631250.0% | |
| ROA | -13.4% | -15.3% | · | -13.9% | -24.9% | -27.2% | · | -29.9% | -18.0% | -21.7% | · | -14.6% | -9.8% | -11.8% | · | -19.8% | |
| ROE | -19.6% | -21.7% | · | -19.3% | -44.8% | -41.2% | · | -45.8% | -24.5% | -28.3% | · | -19.8% | -12.1% | -14.6% | · | 28.0% |
Likuiditas & Solvabilitas 2
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.0 | 5.9 | · | 6.4 | 1.5 | 2.1 | · | 2.1 | 3.1 | 4.0 | · | 4.4 | 5.3 | 5.7 | · | 4.2 | |
| Quick Ratio | 6.2 | 5.1 | · | 5.9 | 0.9 | 1.5 | · | 1.7 | 2.6 | 3.6 | · | 4.0 | 4.7 | 5.2 | · | 3.8 |
Efisiensi 1
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | -0.0 | · | 0.0 | -0.0 | -0.0 | · | -0.0 |
Valuasi (TTM) 10
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $-28.0K | $-28.0K | · | $-28.0K | $-28.0K | $-28.0K | · | $-28.0K | $-28.0K | $-28.0K | · | $-20.0K | $-25.0K | $-28.0K | · | · | |
| Net Income TTM | $-20M | $-25M | · | $-30M | $-32M | $-35M | · | $-33M | $-28M | $-27M | · | $-24M | $-23M | $-22M | · | $-19M | |
| Market Cap | $109M | $68M | · | $119M | $20M | $26M | · | $19M | $67M | $73M | · | $44M | $55M | $58M | · | $46M | |
| P/E | -4.4 | -2.1 | · | -2.4 | -0.5 | -0.5 | · | -0.5 | -2.0 | -2.1 | · | -1.6 | -2.0 | -2.2 | · | -0.2 | |
| P/S | -3904.1 | -2425.3 | · | -4255.8 | -719.2 | -931.8 | · | -683.5 | -2378.1 | -2599.1 | · | -2190.0 | -2217.0 | -2070.3 | · | · | |
| P/B | 3.3 | 2.3 | · | 3.3 | 2.9 | 2.1 | · | 1.3 | 2.9 | 2.5 | · | 1.5 | 1.6 | 1.6 | · | 1.2 | |
| P / Tangible Book | 3.3 | 2.3 | · | 3.3 | 2.9 | 2.1 | · | 1.3 | 2.9 | 2.5 | · | 1.5 | 1.6 | 1.6 | · | 1.2 | |
| P / Cash Flow | · | -12.3 | · | · | · | -2.6 | · | · | · | -10.0 | · | · | · | -21.4 | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | -21.1 | · | · | |
| Earnings Yield | -22.6% | -47.4% | · | -41.5% | -219.3% | -199.5% | · | -196.2% | -50.0% | -47.2% | · | -61.1% | -49.7% | -46.5% | · | -464.7% |
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
Laporan Laba Rugi
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Margin Operasi % | — | — | 187866.7% | 155539.3% | 3202.5% |
| Laba Bersih | $-23M | $-34M | $-26M | $-21M | $-12M |
| EPS Dilusian | $-0.32 | $-0.86 | $-0.86 | $-0.91 | $-3.13 |
Neraca
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Rasio Lancar | 3.4 | 2.7 | 3.4 | 6.1 | 7.5 |
| Rasio Cepat | 2.6 | 2.2 | 2.9 | 5.3 | 7.0 |
Arus Kas
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Arus Kas Bebas | — | $-28M | $-16M | $-19M | $-4M |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
📊
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Pemilik institusional (13F) 70 pengaju · $24.3M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 6 (-8 vs Kuartal sebelumnya) | 13 (+1 vs Kuartal sebelumnya) | 20 (+3 vs Kuartal sebelumnya) | 10 (-2 vs Kuartal sebelumnya) | +986K |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| BIOS Capital Management, LP | $6.324.891 | 5.499.905 | 26,03% | Saham |
| DAVENPORT & Co LLC | $4.898.438 | 4.259.511 | 20,16% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $3.954.591 | 3.438.775 | 16,27% | Saham |
| Chescapmanager LLC | $1.146.583 | 997.029 | 4,72% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $845.023 | 734.329 | 3,48% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $797.281 | 693.288 | 3,28% | Saham |
| Hilton Capital Management, LLC | $631.293 | 548.950 | 2,60% | Saham |
| VANGUARD GROUP INC | $625.973 | 463.684 | 2,58% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $584.453 | 508.220 | 2,41% | Saham |
| CM Management, LLC | $517.500 | 450.000 | 2,13% | Saham |
| Dauntless Investment Group, LLC | $427.456 | 371.701 | 1,76% | Saham |
| Sigma Planning Corp | $416.605 | 362.265 | 1,71% | Saham |
| STATE STREET CORP | $401.330 | 348.983 | 1,65% | Saham |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | $368.575 | 320.500 | 1,52% | Saham |
| UBS Group AG | $251.316 | 218.536 | 1,03% | Saham |
| AMERICAN FINANCIAL GROUP INC | $235.750 | 205.000 | 0,97% | Saham |
| NORTHERN TRUST CORP | $204.932 | 178.202 | 0,84% | Saham |
| Voss Capital, LP | $201.250 | 175.000 | 0,83% | Saham |
| Texas Capital Bank Wealth Management Services Inc | $164.790 | 143.296 | 0,68% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $97.681 | 84.940 | 0,40% | Saham |
| Corient Private Wealth LP | $93.480 | 81.287 | 0,38% | Saham |
| XTX Topco Ltd | $90.242 | 78.471 | 0,37% | Saham |
| McAdam, LLC | $74.236 | 64.553 | 0,31% | Saham |
| FCA CORP /TX | $60.416 | 52.536 | 0,25% | Saham |
| RAYMOND JAMES FINANCIAL INC | $57.328 | 49.850 | 0,24% | Saham |
| Circle Wealth Management, LLC | $56.168 | 48.842 | 0,23% | Saham |
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Management | $55.200 | 48.000 | 0,23% | Saham |
| Bangor Savings Bank | $46.597 | 40.519 | 0,19% | Saham |
| Essex Financial Services, Inc. | $46.000 | 40.000 | 0,19% | Saham |
| JONES FINANCIAL COMPANIES LLLP | $45.521 | 40.644 | 0,19% | Saham |
| GABELLI FUNDS LLC | $34.500 | 30.000 | 0,14% | Saham |
| Bryn Mawr Trust Advisors, LLC | $33.408 | 29.050 | 0,14% | Saham |
| MORGAN STANLEY | $32.054 | 27.873 | 0,13% | Saham |
| HighTower Advisors, LLC | $30.475 | 26.500 | 0,13% | Saham |
| PRIVATE MANAGEMENT GROUP INC | $27.600 | 24.000 | 0,11% | Saham |
| Vanguard Global Advisers, LLC | $27.187 | 23.641 | 0,11% | Saham |
| CWA Asset Management Group, LLC | $26.450 | 23.000 | 0,11% | Saham |
| Creative Planning | $25.530 | 22.200 | 0,11% | Saham |
| Qube Research & Technologies Ltd | $25.070 | 21.800 | 0,10% | Saham |
| GAMCO INVESTORS, INC. ET AL | $23.000 | 20.000 | 0,09% | Saham |
| Cetera Investment Advisers | $22.828 | 19.850 | 0,09% | Saham |
| Rockefeller Capital Management L.P. | $22.116 | 19.231 | 0,09% | Saham |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $20.087 | 17.467 | 0,08% | Saham |
| Focus Partners Wealth | $19.838 | 17.250 | 0,08% | Saham |
| Northeast Financial Consultants Inc | $19.627 | 63.351 | 0,08% | Saham |
| MERCER GLOBAL ADVISORS INC /ADV | $18.344 | 15.951 | 0,08% | Saham |
| CITIZENS FINANCIAL GROUP INC/RI | $15.731 | 13.679 | 0,06% | Saham |
| Bank of New York Mellon Corp | $15.479 | 13.460 | 0,06% | Saham |
| BRADLEY FOSTER & SARGENT INC/CT | $13.480 | 11.722 | 0,06% | Saham |
| Vanguard Personalized Indexing Management, LLC | $13.334 | 11.595 | 0,05% | Saham |
| ELEVATION POINT WEALTH PARTNERS, LLC | $11.546 | 10.040 | 0,05% | Saham |
| Vestmark Advisory Solutions, Inc. | $11.546 | 10.040 | 0,05% | Saham |
| MML INVESTORS SERVICES, LLC | $11.521 | 10.018 | 0,05% | Saham |
| Robertson Stephens Wealth Management, LLC | $11.500 | 10.000 | 0,05% | Saham |
| Retirement Planning Group, LLC | $11.500 | 10.000 | 0,05% | Saham |
| Barry Investment Advisors, LLC | $11.500 | 10.000 | 0,05% | Saham |
| Chicago Partners Investment Group LLC | $10.475 | 10.909 | 0,04% | Saham |
| CITIGROUP INC | $8.763 | 7.620 | 0,04% | Saham |
| FIFTH THIRD BANCORP | $5.750 | 5.000 | 0,02% | Saham |
| OSAIC HOLDINGS, INC. | $4.830 | 4.200 | 0,02% | Saham |
| Versant Capital Management, Inc | $3.746 | 3.257 | 0,02% | Saham |
| Smith Anglin Financial, LLC | $3.718 | 12.000 | 0,02% | Saham |
| WELLS FARGO & COMPANY/MN | $3.450 | 3.000 | 0,01% | Saham |
| Global Retirement Partners, LLC | $2.300 | 2.000 | 0,01% | Saham |
| Ariel Capital Advisors, LLC | $1.578 | 2.250 | 0,01% | Saham |
| Rialto Wealth Management, LLC | $528 | 459 | 0,00% | Saham |
| Virtu Financial LLC | $96 | 83.434 | 0,00% | Saham |
| SBI Securities Co., Ltd. | $58 | 50 | 0,00% | Saham |
| BlackRock, Inc. | $54 | 47 | 0,00% | Saham |
| FMR LLC | $1 | 1 | 0,00% | Saham |
Orang dalam perusahaan 13 orang dalam · 4 pejabat · 7 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Lisa Ricciardi | CEO & President | 16 April 2026 P | 1.715.851 | 1 | 0 | $10.092 |
| John Brendan Doyle | Chief Financial Officer | 1 Mei 2026 F | 618.942 | 1 | 0 | $11.300 |
| James Michael O'Brien | Chief Financial Officer | 23 Maret 2022 A | 5.000 | 0 | 0 | $0 |
| Anthony Caggiano | Chief Medical Officer | 16 April 2026 P | 874.906 | 1 | 0 | $11.100 |
| Peggy Wallace | Direktur | 17 Juni 2026 A | 111.461 | 0 | 0 | $0 |
| Jack A. Khattar | Direktur | 17 Juni 2026 A | 73.500 | 0 | 0 | $0 |
| Brett P Monia | Direktur | 17 Juni 2026 A | 73.500 | 0 | 0 | $0 |
| Ellen B Richstone | Direktur | 17 Juni 2026 A | 83.500 | 0 | 0 | $0 |
| Fletcher Aaron G.L. | Direktur | 19 Sep. 2025 M | 56.229 | 0 | 0 | $0 |
| Mark H. Breedlove | Direktur | 13 Okt. 2021 X | 404.439 | 0 | 0 | $0 |
| Golden Seeds Cognition Therapeutics LLC | Pemilik 10% | 27 Sep. 2022 J | 0 | 0 | 0 | $0 |
| Ogden CAP Associates, LLC | Pemilik 10% | 13 Okt. 2021 X | 2.210.377 | 0 | 0 | $0 |
| BIOS MEMORY SPV I, LP | Pemilik 10% | 13 Okt. 2021 C | 60.065 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Aktivis & pemilik 5%+ 1 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| BIOS MEMORY SPV I, LP, BIOS MEMORY SPV II, LP, BIOS FUND I, LP, BIOS FUND I QP, LP, BP DIRECTORS, LP, BIOS FUND II, LP, BIOS FUND II QP, LP, BIOS FUND II NT, LP, BIOS FUND III, LP, BIOS FUND III QP, LP, BIOS FUND III NT, LP, BIOS CLINICAL OPPORTUNITY FUND, LP, BIOS EQUITY PARTNERS, LP, BIOS EQUITY PARTNERS II, LP, BIOS EQUITY PARTNERS III, LP, BIOS EQUITY COF, LP, CAVU MANAGEMENT, LP, BIOS CAPITAL MANAGEMENT, LP, CAVU ADVISORS, LLC, BIOS ADVISORS GP, LLC, LESLIE W. KREIS, AARON G.L. FLETCHER ×5 pengajuan | 23 Sep. 2025 | 6,80% | Amandemen | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Kepemilikan ETF Dimiliki oleh 4 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.